Proof of Concept for Repair of Sickle Cell Disease By Non-Myeloablative MHC Disparate T Cell Depleted HSCT Combined with Donor-Derived Veto Cells

Proof of Concept for Repair of Sickle Cell Disease By Non-Myeloablative MHC Disparate T Cell Depleted HSCT Combined with Donor-Derived Veto Cells

Proof of Concept for Repair of Sickle Cell Disease By Non-Myeloablative MHC Disparate T Cell Depleted HSCT Combined with Donor-Derived Veto Cells https://cell-source.com/wp-content/themes/movedo/images/empty/thumbnail.jpg 150 150 Cell Source, Inc. Cell Source, Inc. //cell-source.com/wp-content/uploads/2021/10/clcs-logo-2021-negative-glow.png July 16, 2020 May 25, 2022